SCHEMBL24638679

SCHEMBL24638679

C=C/C(O)=C\NNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23890940 0.70
SCHEMBL22667137 0.70
SCHEMBL24339362 0.67
SCHEMBL22167629 0.65 TAS1R3 (0.30)
SCHEMBL22666727 0.65
SCHEMBL21078774 0.64
SCHEMBL18560385 0.63
SCHEMBL10049423 0.61
SCHEMBL2349896 0.61
SCHEMBL14339210 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4245757-A1 CRYSTAL FORM OF FREE BASE OF INHIBITOR CONTAINING BICYCLIC RING DERIVATIVE AND PREPARATION METHOD AND APPLICATION OF CRYSTAL FORM Shanghai Hansoh Biomedical Co., Ltd. (CN) 2023-09-20 EP disclosed
WO-2022168122-A1 PROCESSES FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2022-08-11 WO disclosed